FDA-Drug2026-03-11Class II
Metoprolol Succinate Extended-Release Tablets, 200 mg, 100 tablets bottles, Rx Only, Teva Pharmaceuticals, Parsippany, NJ 07054, NDC: 45963-678-11
Teva Pharmaceuticals USA, Inc
Hazard
Failed Dissolution Specifications
Sold states
Nationwide
Affected count
19,056 bottles
Manufactured in
400 Interpace Pkwy Bldg A, N/A, Parsippany, NJ, United States
Products
Metoprolol Succinate Extended-Release Tablets, 200 mg, 100 tablets bottles, Rx Only, Teva Pharmaceuticals, Parsippany, NJ 07054, NDC: 45963-678-11
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0357-2026Original summary
Metoprolol Succinate Extended-Release Tablets, 200 mg, 100 tablets bottles, Rx Only, Teva Pharmaceuticals, Parsippany, NJ 07054, NDC: 45963-678-11 Failed Dissolution Specifications Lot#: a) 0686H251, 0687H251, 10688H251, Exp.: 02/2027. . Distribution: Nationwide Affected quantity: 19,056 bottles
Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief